1. Complement Protein Levels Decrease with Tumour Severity in Pancreatic Ductal Adenocarcinoma. (2022) Authors: Nsingwane, Z.; Elebo, N.; Mhlambi, N.; Devar, J.; Omoshoro-jones, J.; Smith, M.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of complement proteins C3 & C5 in South African pancreatic ductal adenocarcinoma patients and their potential roles in PDAC progression. (2021) Authors: Nsingwane, Z.; Candy, G.; Devar, J.; Omoshoro, J.; Mhlambi, N.; Elebo, N.; Smith, M.; Nweke, E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune response is inhibited in early pancreatic ductal adenocarcinoma by several mechanisms in a cohort of African patients. (2020) Authors: Nweke, E.; Mhlambi, N.; Nsingwane, Z.; Devar, J.; Smith, M.; Ntwasa, M.; Brand, M.; Omoshoro-Jones, J.; Candy, G. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗